BMC Veterinary Research (Dec 2006)

Intracerebral administration of Interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie

  • Cartoni Claudia,
  • Capuccini Silvia,
  • Petrucci Paola,
  • Ricci Giovanni,
  • Di Bari Michele,
  • Mandara Maria,
  • Nonno Romolo,
  • Pasquali Paolo,
  • Macrì Agostino,
  • Agrimi Umberto

DOI
https://doi.org/10.1186/1746-6148-2-37
Journal volume & issue
Vol. 2, no. 1
p. 37

Abstract

Read online

Abstract Background Prion diseases are characterised by a neurodegenerative pattern in which the function of immune system remains still elusive. In the present study, we evaluate if an exogenous treatment with Interleukin-12 (IL-12) and IL-18, able to activate microglia, is able to affect scrapie pathogenesis. Results Cytokines injected intracranially, induced a strong inflammatory response characterised by TNF-�� production and microglia activation. Two groups of mice were injected intracerebrally with high dose of ME7 strain of scrapie containing IL-12 and IL-18 or sterile saline. Cytokines-treated mice showed a more pronounced accumulation of PrPSc in brain tissues at 90 days post-inoculation and a shorter mean survival times than untreated mice. Conclusion We can conclude that intracerebral administration of IL-12 and IL-18 can modulate scrapie pathogenesis possibly through a microglia-mediated pattern.